Sustained complete cytologic and molecular remission induced by donor leucocyte infusions alone in an acute myeloblastic leukaemia in relapse after bone marrow transplantation

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 423-425

  Buzyn Veil, Agnès ^a   Belanger, Coralie ^a   Audat, Francoise ^a   Hermine, Olivier ^a   Bodemer, Christine ^a   Ribrag, Vincent ^a   Radford, Isabelle ^a   Poirel, Hélène ^b   Chane, Catherine ^b   Valensi, Françoise ^b   Macintyre, Elisabeth ^b   Varet, Bruno ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Laboratoire Central d'Hematologie   (France)

^c NONE

Author keywords

Acute myeloid leukaemia; AML1 ETO; BMT; Graft versus leukaemia; Minimal residual disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; LOMUSTINE; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE TRANSFUSION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 9044243414     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1477.x     Document Type: Article

References (10)

1. Antin, J.H. (1993) Graft-versus-leukemia: no longer an epiphenomenon. Blood, 82, 2273-2277.
2. Chang, K., Fan, Y., Stass, S., Estey, E., Wang, G., Trujillo, J., Erikson, P. & Drabkin, H. (1993) Expression of ALM1-ETO fusion transcripts and detection of minimal residual disease t(8;21) positive acute myeloid leukemia. Oncogene, 8, 983.
3. Chomczynski, P. & Sacchi, N. (1987) Single step method of RNA isolation by acid guanidium isothiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156.
4. Giralt, S., Escudier, S., Kantarjian, H., Deisseroth, A., Freireich, E., Andersson, B.S., O'Brien, S., Andreef, M., Fisher, H., Cork, A., Hirsch-Ginsberg, C., Trujillo, J., Stass, S. & Champlin, R. (1993) Preliminary results of treatment with filgrastim for release of leukemia and myelodysplasia after allogeneic bone marrow transplantation. New England Journal of Medicine, 329, 757-761.
5. Kolb, H.J., De Witte, T., Mittermuller, J., Hertenstein, B., Goldman, J.M., Ljungman, P., Verdonck, L., Holler, E., Thalmaier, K., Bartram, C., for the EBMT Chronic Leukemia Working Party (1995) Graft-versus-leukemia effect of donor buffy coat transfusions on recurrent leukemia after marrow transplantation. Blood, 82, (Suppl. 1), abstract 840.
6. Kumar, L. (1994) Leukemia: management of relapse after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 12, 1710-1717.
7. Popat U., Sekhar, M., Prentice, H.G., Wycherley, J., Lawler, M. & Jones, F. (1995) Donor leucocyte infusions for relapsed acute leukaemias post BMT. British Journal of Haematology, 89, (Suppl. 1), abstract 17.
8. Porter, D.L., Roth, M.S., McGarigle, C., Ferrara, J.L.M. & Antin, J.H. (1994) Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New England Journal of Medicine, 330, 100-106.
9. Szer, J., Grigg, A.P., Sheridan, P. & Sheridan, W.P. (1993) Donor leukocyte infusions after chemotherapy for patients relapsing with acute leukemia following allogeneic BMT. Bone Marrow Transplantation, 11, 109-111.
10. Troussard, X., Rimokh, R., Valensi, F., Leboeuf, D., Fenneteau, O., Guitard, A.-M., Manel, A.-M., Schillinger, F., Leglise, C., Brizard, A., Gardais, J., Lessard, M., Flandrin, G. & Macintyre, E. (1994). Heterogeneity of t(1;19)(q23;p13) acute leukaemias. British Journal of Haematology, 89, 516-526.